Application for this study are now closed
Browse our other trials that are currently recruiting
F00923 RSV Vaccine Trial
Fusion Norwood
RSV (Respiratory Syncytial Virus) is a cold virus that can be especially harmful to the elderly. Fusion Clinical Research are trialling a potential new vaccine against RSV and are looking for participants to help with this trial!
We are looking for healthy adults aged between 18-59 in Part 1 and aged between 60-85 in Part 2 of this trial. If you are interested in participating in this trial, please contact us or fill out an Expression of Interest form today.
Eligibility requirements
- Age: 18 - 85
- Sex: Males & Females
- BMI: 18.5 - 35
- Medical History: No previous RSV vaccine
Payment/Remuneration
- $1300 - $1350 depending on which group you are assigned to and if you complete the trial.